Depressive symptom clusters and biomarkers of monocyte activation, inflammation, and coagulation in people with HIV and depression
- 15 August 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Health Psychology
- Vol. 30 (3) , 590-596
Abstract
We assess associations of somatic and cognitive/affective depressive symptom clusters with monocyte activation (soluble (s)CD14, sCD163), systemic inflammation (interleukin-6 (IL-6), high-sensitivity C-reactive protein (hsCRP)), and coagulation (D-dimer, fibrinogen) in people with HIV (PWH) on suppressive antiretroviral therapy with depression. Utilizing baseline data from a randomized controlled trial, we found no significant associations in linear regression models examining individual depressive symptom clusters; however, models examining both clusters simultaneously showed that the somatic cluster was positively associated with inflammation biomarkers, while the cognitive/affective cluster was negatively associated with inflammation and coagulation biomarkers (suggesting a cooperative suppression effect). Our findings indicate a differential association with depressive symptom clusters and biological mechanisms underlying cardiovascular disease (CVD) in HIV, which may be driven by unique components of each depressive symptom cluster. This line of research could identify subgroups of PWH with depression at elevated CVD risk needing early CVD prevention approaches. Supported by R01 HL126557.Keywords
Funding Information
- Division of Intramural Research (R01 HL126557)
This publication has 12 references indexed in Scilit:
- Examining Depression as a Risk Factor for Cardiovascular Disease in People with HIV: A Systematic ReviewAnnals of Behavioral Medicine, 2022
- Effects of Internet Cognitive-Behavioral Therapy on Depressive Symptoms and Surrogates of Cardiovascular Risk in Human Immunodeficiency Virus: A Pilot, Randomized, Controlled TrialOpen Forum Infectious Diseases, 2020
- Associations of Total, Cognitive/Affective, and Somatic Depressive Symptoms and Antidepressant Use With Cardiovascular Disease–Relevant Biomarkers in HIV: Veterans Aging Cohort StudyPsychosomatic Medicine, 2020
- Inflammation and the dimensions of depression: A reviewFrontiers in Neuroendocrinology, 2020
- Measurement invariance of the patient health questionnaire‐9 (PHQ‐9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005–2016Depression and Anxiety, 2019
- The value of suppressor effects in explicating the construct validity of symptom measures.Psychological Assessment, 2013
- Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta‐analysisHIV Medicine, 2012
- Depression as a risk factor for cardiac mortality and morbidityJournal of Psychosomatic Research, 2002
- The PHQ-9Journal of General Internal Medicine, 2001
- Equivalence of the Mediation, Confounding and Suppression EffectPrevention Science, 2000